COMMUNIQUÉS West-GlobeNewswire

Scythian Biosciences Announces Licencing of Colcanna SAS to Cultivate and Import THC into Colombia
08/08/2018
MMJ Colombia closes purchase of 90% of Colcanna’s issued and outstanding shares TORONTO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – [...]
Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract
08/08/2018
Company provides a comprehensive business update via its second quarter 2018 Form 10-Q filing New incentive plan is aligned with the achievement of two specific stockholder value targets and is intended to replace [...]
GTX Corp Tracking Technology Selected By George Mason University Grant for Study to Predict Wandering
08/08/2018
LOS ANGELES, Aug. 08, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO) , a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, today announced that George Mason [...]
Bavarian Nordic Announces Positive Data from Phase 2 Extension Study of its Universal RSV Vaccine
08/08/2018
Broad antibody and T cell responses against RSV remained durable 1 year post a single vaccination with MVA-BN® RSV in the majority of subjects An annual booster of MVA-BN-RSV induced a broad and robust immune response, [...]
Avid Bioservices to Exhibit at the Bioprocessing Summit 2018
08/08/2018
Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity TUSTIN, Calif., Aug. 08, 2018 ( [...]
Endocyte to Present at the 2018 Wedbush PacGrow Healthcare Conference
08/08/2018
WEST LAFAYETTE, Ind., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
AVROBIO, Inc. to Present at the 2018 Wedbush PacGrow Healthcare Conference
08/08/2018
CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative lentiviral-based gene therapies [...]
UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer
08/08/2018
Life Sciences Veteran Brings Extensive Global Finance, Commercial Operations and Business Development Experience to Prepare UroGen for its Transition from a Clinical Stage Company to Commercialization RA’ANANA, Israel, [...]
Pro-Dex, Inc. CEO, Rick Van Kirk Discusses Company Updates with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
08/08/2018
PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Pro-Dex, Inc. (OTCQB:PDEX) (the “Company”) announced CEO, Rick Van Kirk’s interview on Uptick Newswire’s “Stock Day” Podcast. Jolly began the interview by welcoming Pro-Dex, [...]
Pieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference
08/08/2018
BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
08/08/2018
Breast Density Assessment Software Built on Artificial Intelligence NASHUA, N.H., Aug. 08, 2018 (GLOBE NEWSWIRE) -- iCAD (Nasdaq: ICAD), a global leader in medical technology providing innovative cancer detection and [...]
Selecta Biosciences Announces Second Quarter 2018 Financial Results and Provides Corporate Update
08/08/2018
Expanded three-month Phase 2 data presented at EULAR 2018 continue to indicate that SEL-212 product profile may provide better and more sustained serum uric acid control, fewer flares and less frequent dosing compared [...]
Genmab Announces Submission of U.S. & EU Regulatory Applications Seeking Approval of DARZALEX® (Daratumumab) Split Dosing Regimen
08/08/2018
Media Release sBLA & Type II Variation submitted to U.S. FDA and the EMA respectively, seeking approval of split dosing regimen for DARZALEX Applications seek to update Prescribing Information and Summary of Product [...]
Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress
08/08/2018
Heidelberg, Germany, August 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of innate [...]
Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights
08/08/2018
SHANGHAI, China and CUPERTINO, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- China Food and Drug Administration (CFDA) Accepts the Company’s Investigational New Drug (IND) Applications for anti-CD19 CAR-T Therapy Targeting [...]
Nevakar and Endo Enter into Exclusive Licensing Agreement for Multiple 505(b)(2) Injectable Products
08/08/2018
BRIDGEWATER, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Nevakar Inc., a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today that it recently entered into an [...]
Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Omadacycline New Drug Applications for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections
08/08/2018
BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
IMV Inc. Announces Q2 2018 Financial Results
08/08/2018
Initiated Trading of Common Shares on Nasdaq; Finalized Corporate Name Change Presented New Positive Data at ASCO on the DECIDE1 trial in Ovarian Cancer Advanced Ongoing Clinical Programs with Merck and Incyte HALIFAX, [...]
Sol-Gel Technologies Reports Second Quarter 2018 Financial Results
08/08/2018
NESS ZIONA, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

Pages